SMS PHARMACEUTICALS LTD. - 532815 - Outcome Of Board Meeting Held On 12Th August, 2020
1. Approved the Standalone and consolidated Un-audited Financial Results for the Quarter ended 30th June, 2020 along with the Limited Review Report Accordingly, please find the enclosed the following:- 1. Standalone and Consolidated un-audited Financial Results for the quarter ended 30th June, 2020 along with the Limited Review Report. SMS PHARMACEUTICALS LTD. - 532815 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Advertisement In News Paper
With reference to subject cited above we are herewith enclosing the copies of advertisement issued in newspapers on 8th August, 2020 in 'Financial Express' in English language and in 'Andhra Prabha' in Telugu Language, with respect to intimation of Board Meeting for considering Un-audited financial results for the first quarter and ended 30th June, 2020. SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results Of The Company For The First Quarter Ended On 30Th June, 2020.
SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2020 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Sec. 173 of the Companies Act, 2013 that a meeting of the Board of Directors of the Company will be held on the Wednesday, 12th day of August, 2020, at the Registered Office of the Company, inter alia, for the following items: To consider and approve the Un-audited Financial results of the Company for the First Quarter ended on 30th June, 2020. Please be informed that Insider Trading window of SMS Pharmaceuticals Limited shall remain closed till 14th August, 2020 in view of the above mentioned Board Meeting. SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report under Regulation 24A for the financial year 2019-20 SEBI Circular no. CIR/CFD/CMD1/27/2019, Dt: February 8th, 2019. We are herewith submitting the Annual Secretarial Compliance Report issued by CSB Associates, Mr. C.Sudhir Babu, Practicing Company Secretary in compliance with Regulation 24A of SEBI (LODR) Regulations, 2015 for the financial year 2019-20. SMS PHARMACEUTICALS LTD. - 532815 - REQUEST TO SHAREHOLDERS TO REGISTER EMAIL ADDRESS.
Ref: Regulation 30 (6) read with sub-para 12 of para 'A' of part 'A' of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read with MCA circular no. 20/2020 dated May 5, 2020. SMS PHARMACEUTICALS LTD. - 532815 - REQUEST TO SHAREHOLDERS TO REGISTER EMAIL ADDRESS.
Ref: Regulation 30 (6) read with sub-para 12 of para 'A' of part 'A' of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read with MCA circular no. 20/2020 dated May 5, 2020. SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th June, 2020 In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 we are forwarding herewith a copy of the Certificate dated 7th July, 2020, received from Aarthi Consultants Private Limited, Hyderabad, the Registrar and Share Transfer Agent of the Company for the quarter ended 30th June, 2020. Kindly take the above documents on Record SMS PHARMACEUTICALS LTD. - 532815 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ramesh Babu PotluriDesignation :- Managing Director / Whole Time Director SMS PHARMACEUTICALS LTD. - 532815 - Shareholding for the Period Ended June 30, 2020
SMS Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here SMS PHARMACEUTICALS LTD. - 532815 - Submission Of Half Yearly Disclosure On Related Party Transactions 31-03-2020
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended March 31, 2020.